U.S. Markets close in 31 mins

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.6690-0.0195 (-2.83%)
As of 3:27PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 3.49
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 31.9400
52 Week Low 30.2400
50-Day Moving Average 30.7514
200-Day Moving Average 30.9517

Share Statistics

Avg Vol (3 month) 32.65M
Avg Vol (10 day) 3907.17k
Shares Outstanding 541.74M
Float 32.52M
% Held by Insiders 141.27%
% Held by Institutions 16.53%
Shares Short (Sep 29, 2020) 4397.45k
Short Ratio (Sep 29, 2020) 40.46
Short % of Float (Sep 29, 2020) 41.27%
Short % of Shares Outstanding (Sep 29, 2020) 40.95%
Shares Short (prior month Aug 30, 2020) 4511.23k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Dec 20, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin -97.79%
Operating Margin (ttm)-68.19%

Management Effectiveness

Return on Assets (ttm)-34.02%
Return on Equity (ttm)-681.15%

Income Statement

Revenue (ttm)9.24M
Revenue Per Share (ttm)0.34
Quarterly Revenue Growth (yoy)122.70%
Gross Profit (ttm)4.86M
EBITDA -6.24M
Net Income Avi to Common (ttm)-9.83M
Diluted EPS (ttm)-0.3610
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.78M
Total Cash Per Share (mrq)0.21
Total Debt (mrq)1.44M
Total Debt/Equity (mrq)146.90
Current Ratio (mrq)2.77
Book Value Per Share (mrq)0.03

Cash Flow Statement

Operating Cash Flow (ttm)-4.83M
Levered Free Cash Flow (ttm)-1.75M